Rectal Cancer and Radiation in Colitis

Area of Science:

• Gastroenterology and Oncology
• Surgical Gastroenterology

Background:

• Inflammatory bowel disease (IBD) increases colorectal cancer risk.
• Rectal cancer in IBD patients necessitates adherence to general population oncological principles.
• Standard rectal cancer treatment involves surgery, chemotherapy, and radiation therapy (RT).

Purpose of the Study:

• To review evidence on RT toxicity in IBD patients.
• To analyze surgical strategies and outcomes of ileal-pouch anal anastomosis (IPAA) following RT in IBD patients.
• To address the scarcity of literature on IPAA outcomes post-RT in this population.

Main Methods:

• Comprehensive literature review focusing on RT toxicity in IBD.
• Review of surgical techniques for IPAA in IBD patients previously treated with RT.
• Synthesis of existing data on functional outcomes and complications of IPAA after RT.

Main Results:

• Evidence on RT toxicity in IBD patients is summarized.
• Surgical strategies for IPAA post-RT in IBD are discussed.
• Outcomes of IPAA after RT in IBD patients are reviewed, highlighting limited data.

Conclusions:

• IBD patients with rectal cancer should be managed using established oncological guidelines.
• Further research is needed to fully understand the outcomes of IPAA after RT in IBD patients.
• Optimal management requires careful consideration of RT toxicity and surgical reconstruction strategies.